|国家预印本平台
首页|我国儿童用药政策的量化评价:基于政策一致性评价指数模型

我国儿童用药政策的量化评价:基于政策一致性评价指数模型

Quantitative Evaluation of China's Pediatric Drug Policies Based on Policy Modeling Consistency Index Model

中文摘要英文摘要

背景 ?儿童作为特殊群体受到公众的关注,虽近年来发布了一系列政策保障儿童用药安全,但仍存在药物适宜品种少、不合理用药等问题,亟需科学合理的儿童用药政策推动其发展。目的 ?对我国儿童用药政策文本进行量化评价,为未来的儿童用药政策的制定和完善提供参考,从而推动儿童用药事业的高质量发展。方法 ?基于文本挖掘法对2014—2023年国家层面出台的23份儿童用药政策文件进行处理,构建儿童用药政策的政策一致性评价(PMC)指数模型,通过10个一级变量和41个二级变量对我国23项儿童用药政策进行量化评价分析。结果 ?23项儿童用药政策的PMC指数均值为5.65,PMC 凹陷指数均值为4.35,包括1项优秀级政策、17项良好级政策和5项合格级政策,无完美级政策和不良政策;23项儿童用药政策在政策工具和政策受体上得分较高,在发布机构和政策时效上得分较低。结论 ?我国儿童用药政策总体上处于良好水平,可从政策时效、发布机构和政策内容方面进一步完善。

Background ?Childrenas a special grouphave received public attention. Although a series of policies have been released in recent years to ensure the safety of children's medicationthere are still problems such as fewer suitable varieties of drugs and irrational use of medicationwhich require scientific and reasonable policies on children's medication to promote their development. Objective ?To quantitatively evaluate China's pediatric drug policy texts and provide reference for the formulation and improvement of future pediatric drug policies. Methods ?Based on the text mining method23 pediatric drug policy documents issued at the national level from 2014 to 2023 were processedthe policy modeling consistencyPMC index model of pediatric drug policy was constructedand the quantitative evaluation and analysis of China's 23 pediatric drug policies were carried out through 10 primary variables and 41 secondary variables. Results ?The mean value of PMC index of the 23 policies on pediatric drug was 5.65and the mean value of PMC depression index was 4.35including 1 excellent-grade policy17 good-grade policies and 5 qualified-grade policiesand there were no perfect-grade policies and bad policies. 23 medication policies for children scored high on policy tools and policy receptors and low on publishing organizations and policy timeliness. Conclusion ?China's pediatric drug policy is generally at a good leveland can be further improved in terms of policy timelinessissuing organization and policy content.

罗金萍、孙嘉颖、马东平、陈钟鸣、尹文强、王康、耿铭慧、张宝轩、牟艺帆

儿科学药学

卫生政策用药政策儿童政策一致性评价指数模型定量评价

罗金萍,孙嘉颖,马东平,陈钟鸣,尹文强,王康,耿铭慧,张宝轩,牟艺帆.我国儿童用药政策的量化评价:基于政策一致性评价指数模型[EB/OL].(2024-12-19)[2025-08-16].https://chinaxiv.org/abs/202412.00288.点此复制

评论